Showing results (71-80 of 314) with videos related to
Sort By:
Pageof 32
Clinical Rheumatology|November 24, 2019
A critical review of the reproductive safety of LeflunomideBirgit Pfaller, Anna Pupco, Tom Leibson, et al.Annals of the Rheumatic Diseases|August 14, 2015
Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA scoreMonika M Schoels, Daniel Aletaha, Farideh Alasti, et al.Wiener Klinische Wochenschrift|September 28, 2016
Fever of unknown origin (FUO) revisedManuel Unger, Georgios Karanikas, Andreas Kerschbaumer, et al.Annals of the Rheumatic Diseases|February 2, 2012
Comparative effectiveness and safety of biological treatment options after tumour necrosis factor α inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysisMonika Schoels, Daniel Aletaha, Josef S Smolen, et al.RMD Open|September 30, 2021
In vitro evaluation of disease-modifying antirheumatic drugs against rheumatoid arthritis associated pathogens of the oral microfloraManuel Kussmann, Markus Obermueller, Kathrin Spettel, et al.Annals of the Rheumatic Diseases|February 16, 2025
How to treat undifferentiated arthritis today or tomorrow? A consideration of treatment recommendations in light of current evidenceAnnette H M van der Helm-van Mil, Daniel AletahaAnnals of the Rheumatic Diseases|March 29, 2012
Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity indexDaniel Aletaha, Jose Martinez-Avila, Tore K Kvien, et al.Plos One|July 26, 2019
Analysis of gene expression in rheumatoid arthritis and related conditions offers insights into sex-bias, gene biotypes and co-expression patternsAlexander Platzer, Thomas Nussbaumer, Thomas Karonitsch, et al.Arthritis Research & Therapy|March 16, 2012
Value of self-performed joint counts in rheumatoid arthritis patients near remissionHelga Radner, Johannes Grisar, Josef S Smolen, et al.Frontiers in Immunology|April 10, 2023
Advanced immunophenotyping: A powerful tool for immune profiling, drug screening, and a personalized treatment approachTeresa Preglej, Marie Brinkmann, Günter Steiner, et al.Pageof 32